That explains the nice pop I just saw.
Despite what some people say about Cramer, I think has come to the right conclusion about HIMX.
Hopefully the overall market will right itself Monday so HIMX can take off... those of us that are long would like nothing better.
love: put that jerk on "ignore". I did a long time ago.
As for the markets/ONVO this week. You're right. We were caught in a one-two punch situation. If the markets stabilize over the weekend (i.e. what spooked the market the last few days is seen as overblown), the markets should bounce back next week -- and ONVO too.
That's why, in yesterday's post, I said that ONVO would recover today (didn't happen) or Monday. I had a hunch then that the overall market mania might not have played itself out. Hell! It might continue Monday too if some other dire economic event happens.
But when that plays out, the markets and ONVO will recover. And I think rather quickly. I've seen it happen many times over many years.
30 million... I like.
It keeps getting better and better. Thanks sbacchus for digging these stories out.
Agree with both both. Much like my post earlier "Weak volume yesterday and today".
The market and ONVO will bounce back in a day or two.
Tells me the majority of ONVO holders know it's not going to be long before it reverses course. The genral market, as measured by the Dow, has lost roughly 350-points since the beginning of the week.
If not tomorrow, Monday for sure, will see a bounce up for the market and ONVO. Great time to buy more if you're not finished adding to your position.
Horrible day (really week so far -- lost roughly 350 points from the begging of the week).
Bargain hunters are getting itchy fingers to start buying. As you know, when the market has a good day, and HIMX too, HIMX increases much faster than the general market.
Now's the time to look for a good entry point if you're thinking of adding to your position.
You: "We all agree it is at a premium..." "The reason for the premium price is that, like Microsoft, this company has an edge in a new market potential. They have control over some of the technology that give it a competitive and functional advantage as this science develops."
When is a "premium price" not really a "premium"? When it comes to a company like ONVO. The major players in the biotech/pharma industry know about the potential of this company. They know they are on to the real thing, and therefore, know that ONVO has a huge lead over other companies in this space.
Therefore, I submit that, it's not really a "premium price", it's a "deserved price" for a bright future. The major players recognize this, and bid the price up accordingly. They love it when knuckleheads come out with a ridiculous short story that drives the price down, so they can profit even more in the short term or buy more at a great price.
Bottom line: 2014 will see a rise in pps throughout the year in anticipation of the roll out of liver assays scheduled for the 4th quarter. I wouldn't be surprised though if Murphy and company rolled them out sooner. And there's always the chance of a major biomed/pharma company making a bid for the company anytime between now and the 4th quarter.
So I say let's think of ONVO's price as most any biotech companies price that has a promising product pipeline. "Deserved price" or, at the very least, "deserved premium price". To merely state it has a "premium price", to my way of thinking, is a soft knock on the company which leads to what happened Monday.
Then TD Ameritrade had it right when they had it at sometime the week of Feb 10.
haschultz: good points you touch upon in both your posts in this thread.
But, to hell with hsangha and the other shorts! They'll add more fuel to the fire in days to come.